Javad Boskabadi - Department of Clinical Pharmacy, Faculty of pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Zahra Askari - Department of Toxicology, Faculty of pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Hamideh Abbaspour-kasgari - Department of Clinical Pharmacy, Faculty of pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

The Novel Coronavirus Disease ۲۰۱۹ (COVID-۱۹) was identified firstly in CHINA. Manifestation of this disease can be in wide range from asymptomatic to severe critical disease. All gender and ages are at risk for Covid-۱۹ infection in other hand, COVID-۱۹ was known as respiratory infectious disease but this infection may present with other organ injury. Although effective drug for COVID-۱۹ treatment not approved but some antiviral agents and immune modulating treatments may be beneficial. The aim of this study is to evaluate the medications using for treatment patients with Covid-۱۹ infection. Although effective treatment not approved for covid-۱۹ but Remdesivir, as antiviral agent, and dexamethasone are recommended for use in hospitalized patients.

Antiviral Agents, Covid-۱۹, Drug Treatment, Global Pandemic